About Us

About Us About Us

About Toolgen

About Us

About Us



on service : work day 08:30~17:30


ToolGen was founded in 1999 by Dr. Kim, Jin-su, who was professor of chemistry at Seoul National University(SNU) and incumbent(2014~) Chief of Genome Engineering Center of Institute of Basic Science(IBS).

ToolGen has been devoting itself to develop genome editing technology. Toolgen has been doing successfully in developing ZFN(Zinc Finger Nuclease), TALEN(TAL effector nuclease) and CRISPR/Cas9 progressively which are known as 1st Generation, 2nd Generation and 3rd Generation genome editing tool respectively.

ToolGen has been identifying itself as Global Bio-tech Company based on CRISPR technology. ToolGen is concentrating it’s competency on Innovative Human Therapeutics, Molecular Breeding of Plant and Animal and Reliable CRISPR/Cas9 technology.

ToolGen is also identifying itself as CRISPR products and services provider for researchers both in Korea and global world.

Intellectual Property(IP) on Source Technology in Genome Editing

ToolGen registered technology on ZFN, TALEN and CRISPR/Cas9 as Intellectual Property in Korea respectively in 2004, 2015, 2016 respectively.

ToolGen registered ZFN technologies in 7 countries including Newzealand, Australia, EU, India, Canada, Japan and China.

ToolGen’s CRISPR/Cas9 technologies are under examination among 9 countries including USA, Canada, China, EU, India, Japan, Singapore, Hongkong and Brazil. Toolgen got approvement at Australia in 2016.

ToolGen possessed 29 registered patents and 16 under patent examination as of 2016 both in Korea and out of Korea.

Research and Development

  • Based on CRISPR/Cas9 source technology, Toolgen has been operating several key therapeutic development projects with view to commercialize. Toolgen has been also doing it’s best effort to make research & development network with global competent partners. Toolgen has vision to establish CRISPR platform which can be shared with innovative partners from both academic and business worldwide.

Distributor Network

  • ToolGen has estblished CRISPR/Cas9 distributing network globally with PNA bio in USA, TAKARA bio in Japan, Biotools in Taiwan, Labomics in Eu(Belgium), CambioScience in Eu(England) and BMS, Cosmogenetech in Korea.

Brief History

  • 1999 Establishment
  • 2002 The most notable 10 bio-tech company in Asia(by Pacific Rim Forum)
  • 2003 ZFN development
  • 2004 ZFN IP registered in Korea(registered in 7 countries)
  • 2005 Top 8 brand nominated( by Ministry of Science and Technology)
  • 2011 TALEN development
  • 2012 CRISPR/Cas9 development
  • 2012 CRISPR/Cas9 IP propose in USA(do in 8 countries progressively)
  • 2013 Breakthrough of the year, Runner-up nominee(Science)
  • 2014 KONEX registered
  • 2014 Top 10 breakthrough technology(MIT Technology Review)
  • 2015 TALEN technology IP registered in Korea
  • 2015 Top 10 emenrging technology(WEF)
  • 2015 KONEX award for best technology company
  • 2016 CRISPR/Cas9 technology IP registerd in Korea

#1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, South Korea T. 02-873-8168 F. 02-873-8169 E. info@toolgen.com

Copyright 2017ⓒ ToolGen, Inc. All Rights Reseved [admin]